The Patent Finder

Terms ending in 2031

Amgen Inc.

Every in-force patent on Amgen Inc.'s record whose computed term ends in 2031, whoever holds it now. Soonest term end first, then patent number.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleHolderStatusExpiresConfidence
US 8,790,313Syringe Adapter
In force
 · High confidence
Amgen Inc.In forceHigh confidence
US 8,883,151IL-17 Receptor Antibody Formulation
In force
 · High confidence
Amgen K-A, Inc.In forceHigh confidence
US 10,808,033IL-17 Receptor Antibody Formulation
In force
 · High confidence
Amgen K-A, Inc.In forceHigh confidence
US 11,505,612Method of Treating Diseases Using an IL-17 Receptor Antibody Formulation
In force
 · High confidence
Amgen K-A, Inc.In forceHigh confidence
US 8,735,384Amino Heteroaryl Compounds as Beta-Secretase Modulators and Methods of Use
In force
 · High confidence
Amgen Inc.In forceHigh confidence
US 8,222,251Pyridopyridazine Compounds, Compositions and Methods of Use
In force
 · High confidence
Amgen Inc.In forceHigh confidence
US 9,302,056Vaccination syringe
In force
 · High confidence
Amgen Inc.In forceHigh confidence
US 10,213,562Vaccination syringe
In force
 · High confidence
Amgen Inc.In forceHigh confidence
US 8,415,485Processes for the Preparation of 2-(1-Phenylethyl)isoindolin-1-one Compounds
In force
 · High confidence
Amgen Inc.In forceHigh confidence
US 8,163,909Substituted Hydroxyethyl Amine Compounds as Beta-Secretase Modulators and Methods of Use
In force
 · High confidence
Amgen Inc.In forceHigh confidence
47 more term ends in 2031 · Pro
10 of 57 patents shown. Soonest term end first, then patent number.
Pro members see all 57.
Upgrade to Pro
51 of these are in force and held by Amgen Inc..
Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited